Raras
Buscar doenças, sintomas, genes...
Displasia epifisária múltipla tipo 7
Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

📋

Displasia epifisária múltipla (DEM), também conhecida como doença de Fairbank, é uma doença genética rara que afeta as extremidades em crescimento dos ossos. Os ossos longos normalmente se alongam pela expansão da cartilagem na placa de crescimento próximo às suas extremidades. À medida que se expande para fora da placa de crescimento, a cartilagem se mineraliza e endurece para se tornar osso (ossificação). Na DEM, esse processo é deficiente.

Publicações científicas
491 artigos
Último publicado: 1993

Escala de raridade

CLASSIFICAÇÃO ORPHANET · BRASIL 2024
<1 / 1 000 000
Ultra-rara
<1/50k
Muito rara
1/20k
Rara
1/10k
Pouco freq.
1/5k
Incomum
1/2k
Prevalência
0.0
Worldwide
Casos conhecidos
2
pacientes catalogados
Início
Childhood
🏥
SUS: Cobertura mínimaScore: 15%
CID-10: Q77.3
🇧🇷Dados SUS / DATASUS
PROCEDIMENTOS SIGTAP (5)
0202010503
Cariótipo — bandas G, Q ou Rgenetic_test
0202010600
Pesquisa de microdeleções/microduplicações por FISHlab_test
0202010694
Sequenciamento completo do exoma (WES)rehabilitation
0202010260
Dosagem de alfa-fetoproteína
0301070040
Atendimento em reabilitação — doenças raras
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Características mais comuns

100%prev.
Hipoplasia da epífise femoral capital
Frequência: 2/2
100%prev.
Baixa estatura leve
Frequência: 2/2
100%prev.
Colo femoral em chave de macaco
Frequência: 2/2
100%prev.
Colo femoral curto
Obrigatório (100%)
100%prev.
Ossificação avançada dos ossos do carpo
Obrigatório (100%)
100%prev.
Platispondilia
Frequência: 2/2
11sintomas
Muito frequente (10)
Sem dados (1)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 11 características clínicas mais associadas, ordenadas por frequência.

Hipoplasia da epífise femoral capitalHypoplasia of the capital femoral epiphysis
Frequência: 2/2100%
Baixa estatura leveMild short stature
Frequência: 2/2100%
Colo femoral em chave de macacoMonkey wrench femoral neck
Frequência: 2/2100%
Colo femoral curtoShort femoral neck
Obrigatório (100%)100%
Ossificação avançada dos ossos do carpoAdvanced ossification of carpal bones
Obrigatório (100%)100%

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa5
Total histórico491PubMed
Últimos 10 anos200publicações
Pico202353 papers
Linha do tempo
2021Hoje · 2026📈 2023Ano de pico
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

Genes associados

1 gene identificado com associação a esta condição.

CANT1Soluble calcium-activated nucleotidase 1Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Calcium-dependent nucleotidase with a preference for UDP. The order of activity with different substrates is UDP > GDP > UTP > GTP. Has very low activity towards ADP and even lower activity towards ATP. Does not hydrolyze AMP and GMP (PubMed:12234496, PubMed:15006348, PubMed:15248776, PubMed:16835225). Involved in proteoglycan synthesis (PubMed:22539336)

LOCALIZAÇÃO

Endoplasmic reticulum membraneGolgi apparatus, Golgi stack membraneCell membrane

VIAS BIOLÓGICAS (1)
Neutrophil degranulation
MECANISMO DE DOENÇA

Desbuquois dysplasia 1

A chondrodysplasia characterized by severe prenatal and postnatal growth retardation (less than -5 SD), joint laxity, short extremities, progressive scoliosis, round face, midface hypoplasia, prominent bulging eyes. The main radiologic features are short long bones with metaphyseal splay, a 'Swedish key' appearance of the proximal femur (exaggerated trochanter), and advance carpal and tarsal bone age. Two forms of Desbuquois dysplasia are distinguished on the basis of the presence or absence of characteristic hand anomalies: an extra ossification center distal to the second metacarpal, delta phalanx, bifid distal thumb phalanx, and phalangeal dislocations.

VIAS REACTOME (1)
OUTRAS DOENÇAS (3)
Desbuquois dysplasia 1epiphyseal dysplasia, multiple, 7Desbuquois dysplasia
HGNC:19721UniProt:Q8WVQ1

Variantes genéticas (ClinVar)

75 variantes patogênicas registradas no ClinVar.

🧬 CANT1: NM_001159773.2(CANT1):c.350C>G (p.Ser117Ter) ()
🧬 CANT1: NM_001159773.2(CANT1):c.885G>A (p.Trp295Ter) ()
🧬 CANT1: NM_001159773.2(CANT1):c.360_370del (p.Gln120fs) ()
🧬 CANT1: NM_001159773.2(CANT1):c.-146-324G>A ()
🧬 CANT1: GRCh37/hg19 17q24.3-25.3(chr17:70161447-81041938)x3 ()
Ver todas no ClinVar

Classificação de variantes (ClinVar)

Distribuição de 1,355 variantes classificadas pelo ClinVar.

339
339
677
Patogênica (25.0%)
VUS (25.0%)
Benigna (50.0%)
VARIANTES MAIS SIGNIFICATIVAS
COL2A1: NM_001844.5(COL2A1):c.2957C>T (p.Pro986Leu) [Likely pathogenic]
COL2A1: NM_001844.5(COL2A1):c.2464-2A>T [Likely pathogenic]
SLC26A2: NM_000112.4(SLC26A2):c.1651_1652dup (p.Ser551fs) [Pathogenic]
SLC26A2: NM_000112.4(SLC26A2):c.1946_1947del (p.Ile649fs) [Pathogenic]
SLC26A2: NM_000112.4(SLC26A2):c.-26+1G>T [Likely pathogenic]

Vias biológicas (Reactome)

1 via biológica associada aos genes desta condição.

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Displasia epifisária múltipla tipo 7

🗺️

Selecione um estado ou use sua localização para ver resultados.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

Pesquisa e ensaios clínicos

Nenhum ensaio clínico registrado para esta condição.

🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

Timeline de publicações
118 papers (10 anos)
#1

Once-Weekly Navepegritide in Children With Achondroplasia: The APPROACH Randomized Clinical Trial.

JAMA pediatrics2026 Jan 01

Historically considered a skeletal dysplasia characterized by disproportionate short stature, achondroplasia is a condition with multisystemic effects due to the widespread expression of the fibroblast growth factor receptor 3 variant throughout the body, impacting muscle, neurological function, cardiorespiratory health, and health-related quality of life. To evaluate the efficacy, safety, and tolerability of once-weekly navepegritide, an investigational prodrug of C-type natriuretic peptide, while assessing benefits beyond growth that may have important implications for complications and health-related quality of life in children with achondroplasia. Enrollment for this pivotal phase 2b, randomized, double-blind, placebo-controlled trial (APPROACH) was conducted between March and August 2023 at 10 hospitals in Australia, Canada, Denmark, Ireland, New Zealand, Spain, and the US with randomized, blind treatment through 52 weeks and an open-label extension (ongoing). Eligible participants aged 2 to 11 years had achondroplasia confirmed by genetic testing, were naive to treatment with growth-promoting agents, and had their height recorded at least 6 months prior to randomization. Enrolled participants were stratified by age and sex. Those with radiographic evidence of closed growth plates, planned bone surgery, severe untreated sleep apnea, or medical conditions known to affect growth were excluded (n = 2 of 86); of 84 participants enrolled, all were analyzed for safety and efficacy outcomes, including 2 who discontinued treatment. Navepegritide (100 μg/kg/wk) or placebo administered by once-weekly subcutaneous injection. The primary end point was annualized growth velocity at week 52. Other clinically important secondary measures included radiographically assessed skeletal outcomes and health-related quality of life, evaluated using Achondroplasia Child Experience Measures. Safety assessments included adverse events, clinical laboratory assessments, bone age, and immunogenicity. Eighty-four participants were enrolled and assigned randomly in a 2:1 ratio to receive navepegritide (n = 57; mean [SD] age, 5.6 [2.6] years; 31 [54%] male) or placebo (n = 27; mean [SD] age, 6.0 [2.7] years; 14 [52%] male). All randomized participants were included in efficacy and safety analyses, although 2 patients in the navepegritide group discontinued treatment (one at week 26 and the other at week 34). The trial met its primary end point, demonstrating superiority of navepegritide in annualized growth velocity at week 52 vs placebo (least-squares mean treatment difference of 1.49 cm/y; 95% CI, 1.05 to 1.93; P < .001). Treatment resulted in improvements (least-squares mean treatment difference [95% CI]) in tibial-femoral angle (-1.81° [-3.16 to -0.47]), mechanical axis deviation (-2.78 mm [-4.71 to -0.86]), fibula to tibia length ratio (-0.016 [-0.024 to -0.008]), and Achondroplasia Child Experience Measures-Physical Functioning (-11.1 [-21.5 to -0.80] in children younger than 5 years). No serious adverse events were treatment-related, and no deaths occurred. Injection site reaction rates were low, and no symptomatic hypotension or fractures were observed. In this randomized clinical trial, navepegritide treatment resulted in statistically significantly higher annualized growth velocity in children with achondroplasia, with a similar safety and tolerability profile vs placebo. Moreover, navepegritide demonstrated additional potential health benefits beyond growth. ClinicalTrials.gov Identifier: NCT05598320.

#2

Genetic and Clinical Spectrum of Osteogenesis Imperfecta in an Egyptian Cohort With a High Rate of Lethal Phenotypes.

Clinical genetics2026 Apr

Osteogenesis imperfecta (OI) is a genetically heterogeneous connective tissue disorder marked by bone fragility and deformities. This study aimed to define the clinical and molecular characteristics of 21 OI patients from 15 unrelated Egyptian families. Most probands were analyzed by exome sequencing. In three consanguineous cases, variants were identified through SNP array-based homozygosity mapping followed by direct sequencing of a candidate gene. Genotype-phenotype correlations were additionally explored. Parental consanguinity was documented in 66.7% (10/15) of the total cohort and in 100% (8/8) of the families with autosomal recessive OI. Pathogenic or likely pathogenic variants were identified in 14 families, five of which were novel. A variant of uncertain significance was identified in the remaining family. COL1A1 and COL1A2 (n = 7) were the most commonly mutated genes, followed by CRTAP (n = 4), while variants in P3H1, WNT1, CREB3L1, and SEC24D were each identified in a single patient. The present study highlights the molecular heterogeneity of OI. In total, 15 distinct variants in seven OI-related genes were identified. We also report a particularly high number of OI lethal forms affecting 10 patients out of 21. The study adds further evidence for the utility of ES in the genetic diagnosis of OI, which facilitates counseling and personalized care.

#3

Genotype-phenotype correlations in PSACH/EDM1 patients with COMP gene variants: a comprehensive review of 830 cases.

Frontiers in endocrinology2026

Pseudoachondroplasia (PSACH) and multiple epiphyseal dysplasia-1 (EDM1) are two rare skeletal diseases that represent distinct endpoints of a continuous phenotypic spectrum with substantial clinical overlap, caused by variants in the gene coding cartilage oligomeric matrix protein (COMP). To summarize the clinical characteristics of PSACH/EDM1 and variants of COMP gene, as well as to explore the correlations between them. PubMed, China National Knowledge Infrastructure, and Wanfang were searched for case reports and case series of patients with genetic diagnosis of PSACH/EDM1 from the inception to 24 March 2025. The clinical characteristics and gene variants of enrolled patients were analyzed and compared to explore genotype-phenotype correlation. A total of 830 PSACH/EDM1 patients (471probands) harboring 224 different variants of COMP gene were enrolled from 106 articles, with missense variants accounting for the majority (80.8%). Exon 13 (183 probands, 38.9%) and type III (T3) repeat domain (413 probands, 87.7%) were the most commonly affected regions, with c.1417_1419del (p.Asp473del) being the most common hotspot variant. Compared with EDM1, PSACH manifested earlier age of onset (p < 0.001), shorter stature (p < 0.001), higher rates of lower limb deformity (p < 0.001), joint laxity (p = 0.041), anterior beaking of the vertebra and irregular/flared metaphysis (p < 0.001), while lower rate of joint pain/osteoarthritis (p < 0.001) and abnormal femoral head (p = 0.008). Missense variants in T3-4 and T3-5 were more likely to cause EDM1 (all p < 0.001), while those in T3-1 and T3-6 to T3-8 were associated with a greater frequency of PSACH (p = 0.002 to 0.023). Majority of in-frame variants were found in PSACH, as c.1417_1419del (p.Asp473del) being PSACH specific. PSACH exhibits more severe phenotypes than EDM1, even with phenotypic overlap. In-frame variants are more strongly associated with PSACH, as the hotspot variant p.Asp473del exclusively identified in PSACH. In contrast, missense variants in T3-4 and T3-5 show a stronger association with EDM1.

#4

In Individuals with Osteogenesis Imperfecta, Cephalometric Findings Suggest that Bisphosphonate Therapy May Improve Craniofacial Growth.

Calcified tissue international2026 Jan 31

Osteogenesis imperfecta is a rare hereditary condition affecting type 1 collagen formation. Among the wide spectrum of phenotypic features, osteogenesis imperfecta variably impairs craniofacial growth, affecting facial morphology and predisposing to malocclusion. At present, bisphosphonates are the gold standard for treatment of osteogenesis imperfecta, but knowledge on the effect of the medication on craniofacial growth is lacking. This retrospective study analysed lateral skull radiographs of 36 growing individuals with osteogenesis imperfecta and bisphosphonate treatment history (mean age 10.0 years, 13 females). Of them, 23 had been diagnosed with type I, 8 with type III, and 5 with type IV osteogenesis imperfecta. The historical control group that had not received bisphosphonate therapy comprised 34 individuals (mean age 8.1 years, 22 females) with osteogenesis imperfecta, type I in 18, type III in 7, and type IV in 9 individuals. The cephalometric measurement values were converted into age- and sex-matched Z-scores based on normal population values of the same ethnicity. Inter-group comparisons of the Z-scores showed several statistically significant differences where the bisphosphonate treatment group deviated less from unaffected population than the historical group. These included one or more of the mandibular size measurements in all studied types of osteogenesis imperfecta, anterior facial height and maxillary length in type IV, as well as cranial base angle, posterior facial height and angulation between the jaws in type III. Our findings suggest that bisphosphonate therapy may positively enhance both mid-facial and mandibular craniofacial growth in individuals with osteogenesis imperfecta.

#5

The SAPHO syndrome in diffuse sclerosing osteomyelitis of the mandible: an oral and maxillofacial surgery perspective.

Oral surgery, oral medicine, oral pathology and oral radiology2026 Mar

To compare the characteristics of patients with isolated diffuse sclerosing osteomyelitis of the mandible (DSOM) and those with DSOM along with systemic bone, joint, and cutaneous lesions, and discuss the relationship between DSOM and the synovitis, acne, pustulosis, hyperostosis, and osteitis (SAPHO) syndrome from the perspective of oral and maxillofacial surgery. A total of 446 DSOM patients were included. They were divided into simple DSOM and syndrome-type DSOM groups based on their systemic manifestations. Their demographic data, clinical features, imaging findings (maxillofacial CT and bone scintigraphy), and laboratory results (bone turnover markers (BTMs) and inflammatory markers) were compared. Compared to patients with syndrome-type DSOM, those with simple DSOM had a younger median age of onset (13 vs 25 years), a higher proportion of women (69.8% vs 45.5%), lower bilateral mandibular involvement (18.3% vs 29.9%), a higher prevalence of periosteal reaction (70.6% vs 59.7%, p = .017), elevated BTMs (osteocalcin: 49.73 vs 21.69 ng/mL; β-CTX: 0.94 vs 0.53 ng/mL), and lower C-reactive protein levels (3.00 vs 7.48 mg/L). Nearly half of all patients with DSOM exhibited systemic bone, joint, or cutaneous manifestations. The characteristics of simple DSOM and syndrome-type DSOM are highly overlapped, but the differences in age, gender distribution, radiographic findings and bone metabolic activity suggest that they may be different stages or subtypes of the same disease.

Publicações recentes

Ver todas no PubMed

📚 EuropePMC250 artigos no totalmostrando 200

2026

Genotype-phenotype correlations in PSACH/EDM1 patients with COMP gene variants: a comprehensive review of 830 cases.

Frontiers in endocrinology
2026

In Individuals with Osteogenesis Imperfecta, Cephalometric Findings Suggest that Bisphosphonate Therapy May Improve Craniofacial Growth.

Calcified tissue international
2025

Beyond papilledema: optic disc clues reveal coexisting Chiari I malformation and osteopetrosis-a case report and systematic review.

Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery
2026

Once-Weekly Navepegritide in Children With Achondroplasia: The APPROACH Randomized Clinical Trial.

JAMA pediatrics
2025

Achondroplasia and hypochondroplasia in France: a nationwide epidemiological analysis.

Orphanet journal of rare diseases
2026

The SAPHO syndrome in diffuse sclerosing osteomyelitis of the mandible: an oral and maxillofacial surgery perspective.

Oral surgery, oral medicine, oral pathology and oral radiology
2026

Genetic and Clinical Spectrum of Osteogenesis Imperfecta in an Egyptian Cohort With a High Rate of Lethal Phenotypes.

Clinical genetics
2026

Perfusion Magnetic Resonance Imaging is the Best Way to Predict the Occurrence of Avascular Necrosis in Slipped Capital Femoral Epiphysis.

Journal of pediatric orthopedics
2025

Intramedullary telescopic nailing method applied in cases with osteogenesis imperfecta and our results.

BMC musculoskeletal disorders
2025

C-type natriuretic peptide and collagen X marker are aberrant in skeletal dysplasias.

Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research
2025

Bizarre Parosteal Osteochondromatous Proliferation Revisited.

In vivo (Athens, Greece)
2025

Balancing challenges: exploring postural stability in osteogenesis imperfecta.

Acta of bioengineering and biomechanics
2025

Sleep apnea in patients with achondroplasia associated with foramen magnum stenosis.

Journal of neurosurgery. Pediatrics
2025

[An update review of advances in the treatment of achondroplasia].

Zhonghua er ke za zhi = Chinese journal of pediatrics
2025

Wolcott-Rallison syndrome: late-onset diabetes, multiple epiphyseal dysplasia, and acute liver failure - a case report.

Journal of pediatric endocrinology &amp; metabolism : JPEM
2025

Anti-transforming growth factor-β treatment shows increased bone mass and strength in a novel mouse model for osteogenesis imperfecta type I.

Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research
2025

Novel LBR pathogenic variants with loss of sterol reductase activity participate in the pathogenesis of skeletal dysplasia via dysregulating canonical Wnt pathway.

Biochimica et biophysica acta. Molecular basis of disease
2025

Maternal Health and Safety Outcomes of Prenatal Myostatin Inhibition in Osteogenesis Imperfecta Mice.

Endocrinology
2025

Monoallelic TYROBP deletion is a novel risk factor for Alzheimer's disease.

Molecular neurodegeneration
2025

Hypertrichosis associated with the use of C-type natriuretic peptide analogue: a case report.

Journal of medical case reports
2025

Long-term follow-up of metatropic dysplasia caused by novel mutations in the TRPV4 gene: Case report and literature review.

Medicine
2025

Hearing loss in Chinese osteogenesis imperfecta patients.

European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery
2025

X-linked dominant chondrodysplasia punctata due to novel mutation in EBP gene: A case report.

Medicine
2025

Genetic landscape and phenotypic spectrum of osteogenesis imperfecta in the Kazakhstani pediatric population.

Scientific reports
2025

Atlantoaxial Instability in Collagen Type 2 Skeletal Dysplasias: Surgical Indications and Recommendations.

Journal of pediatric orthopedics
2025

Functional Change in a Child With Achondroplasia Following 12 Months Treatment With Vosoritide-A Case Report.

American journal of medical genetics. Part A
2025

COL1A1 and COL1A2 Gene Variants Causing Osteogenesis Imperfecta in a Major Referral Center of India.

American journal of medical genetics. Part A
2025

Trichorhinophalangeal syndrome type 1 (TRPS1) in breast pathology: diagnostic utility and pitfalls.

Diagnostic pathology
2024

Metabolomics study of osteopetrosis caused by CLCN7 mutation reveals novel pathway and potential biomarkers.

Frontiers in endocrinology
2025

Early life functional transitions impact craniofacial morphology in osteogenesis imperfecta.

Anatomical record (Hoboken, N.J. : 2007)
2025

Clinical Features of Seven COL2A1 Variations in Chinese Children With Type II Collagen Disorders.

Acta paediatrica (Oslo, Norway : 1992)
2025

Bizarre parosteal osteochondromatous proliferation in the jaws: a systematic review.

Oral and maxillofacial surgery
2025

Mastication and electrical activation in the masseter and anterior temporalis muscles of children and adolescents with osteogenesis imperfecta.

CoDAS
2025

Approach to the Patient with Achondroplasia-New Considerations for Diagnosis, Management, and Treatment.

The Journal of clinical endocrinology and metabolism
2025

Deficiency of EXT1 and FGFR3 genes promotes chondrocyte differentiation, leading to the induction of osteochondroma formation.

Bone
2024

Otologic Manifestations in Patients with Achondroplasia: A Multicenter Study.

The journal of international advanced otology
2025

Foetal achondroplasia: Prenatal diagnosis, outcome and perspectives.

Journal of gynecology obstetrics and human reproduction
2025

COL9A1-related disorder with pectus carinatum, without epiphyseal dysplasia: case report and review of literature.

Skeletal radiology
2024

Lung function in adult patients with osteogenesis imperfecta: a cohort study.

Orphanet journal of rare diseases
2024

Clinical Challenges in Diagnosing Primordial Dwarfism: Insights from a MOPD II Case Study.

Medicina (Kaunas, Lithuania)
2025

Effects of shear stress on mesenchymal stem cells of patients with osteogenesis imperfecta.

Orthopaedics &amp; traumatology, surgery &amp; research : OTSR
2024

Bmpr1aa modulates the severity of the skeletal phenotype in an fkbp10-deficient Bruck syndrome zebrafish model.

Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research
2025

Genetics and Bone Mineral Density Predict the Fractures in Adults With Osteogenesis Imperfecta: A Prospective Study.

The Journal of clinical endocrinology and metabolism
2024

Epidemiology of bone tumors in children and adolescents: a retrospective study of 266 patients in the south of Tunisia.

Acta orthopaedica Belgica
2025

DYNC2H1 splicing variants causing severe prenatal short-rib polydactyly syndrome and postnatal orofaciodigital syndrome.

Annals of human genetics
2024

A Single Multiplex PCR and Single-Nucleotide Extension Assay for the Detection of Common Thanatophoric Dysplasia I and II Mutations.

The Journal of molecular diagnostics : JMD
2024

Oral Problems in Brazilian Individuals with Rare Genetic Diseases That Affect Skeletal Development.

International journal of environmental research and public health
2024

Persistent growth-promoting effects of vosoritide in children with achondroplasia are accompanied by improvements in physical and social aspects of health-related quality of life.

Genetics in medicine : official journal of the American College of Medical Genetics
2025

Risk of Pulmonary Diseases in Osteogenesis Imperfecta in Denmark: A Register-Based Cohort Study.

Chest
2024

Evaluation of the Nordic Musculoskeletal Questionnaire for Measuring Prevalence and the Consequence of Pain in a Danish Adult OI Population: A Pilot Study.

Calcified tissue international
2024

Characterization of hearing loss in pediatric patients with osteogenesis imperfecta.

International journal of pediatric otorhinolaryngology
2024

Genotype and Phenotype Correlation of Patients with Osteogenesis Imperfecta.

The Journal of molecular diagnostics : JMD
2025

Efficacy of intraoperative use of tranexamic acid in reducing blood loss from telescoping nail application in osteogenesis imperfecta. A randomized controlled trial.

Orthopaedics &amp; traumatology, surgery &amp; research : OTSR
2024

Effectiveness of whole exome sequencing analyses in the molecular diagnosis of osteogenesis imperfecta.

Journal of pediatric endocrinology &amp; metabolism : JPEM
2024

[Analysis of genetic variants and molecular pathogenesis in a Chinese pedigree affected with Multiple epiphyseal dysplasia].

Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics
2024

Meier-Gorlin syndrome type 7: a rare cause of primordial dwarfism: two new cases and literature review.

Clinical dysmorphology
2024

[Examination of Optimal Frequency Processing in X-ray Images for Occult Femoral Neck Fractures].

Nihon Hoshasen Gijutsu Gakkai zasshi
2024

Molecular Genetic Diagnosis with Targeted Next Generation Sequencing in a Cohort of Turkish Osteogenesis Imperfecta Patients and their Genotype-phenotype Correlation.

Journal of clinical research in pediatric endocrinology
2024

A Retrospective Study of the Presentation, Diagnosis, Management, and Outcomes of 27 Patients with Osteogenesis Imperfecta at a Single Center in Türkiye.

Medical science monitor : international medical journal of experimental and clinical research
2024

Total Knee Arthroplasty in Patients Who Have Skeletal Dysplasia: A Center's Experience With a Mean 9-Year Follow-Up.

The Journal of arthroplasty
2024

A recurrent de novo missense mutation in COL1A1 causes osteogenesis imperfecta type II and preterm delivery in Normande cattle.

Genetics, selection, evolution : GSE
2024

A case of osteogenesis imperfecta diagnosed after subchondral insufficiency fracture of bilateral femoral heads.

Modern rheumatology case reports
2024

Three-dimensional evaluation of dental characteristics in patients with Cleidocranial dysplasia.

BMC oral health
2024

Changes in serum bone turnover markers and bone mineral density Z-score in children with osteogenesis imperfecta after zoledronic acid treatment.

Journal of investigative medicine : the official publication of the American Federation for Clinical Research
2024

Long-term Outcomes of Surgically Treated Congenital Dislocation of the Knee.

Journal of pediatric orthopedics
2024

Surgery for Spinal Stenosis in Achondroplasia: Causes of Reoperation and Reduction of Risks.

Journal of pediatric orthopedics
2024

Promising horizons in achondroplasia along with the development of new drugs.

Endocrine journal
2024

Association between treatment type and therapeutic response according to clinical form of SAPHO syndrome in adults from a multicentre retrospective cohort study.

Clinical and experimental rheumatology
2024

Bone microarchitecture and strength assessment in adults with osteogenesis imperfecta using HR-pQCT: normative comparison and challenges.

Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research
2024

Patient and Caregiver Impressions of the Impact of Madelung Deformity: A CoULD Registry Analysis.

The Journal of hand surgery
2024

Short-term effects of Mediterranean diet on nutritional status in adults affected by Osteogenesis Imperfecta: a pilot study.

Orphanet journal of rare diseases
2024

Intraoperative Epiphyseal Perfusion Monitoring Does Not Reliably Predict Osteonecrosis Following Treatment of Unstable SCFE.

Journal of pediatric orthopedics
2024

Surgical treatment of osteogenesis imperfecta: a summary of the incidence of femoral implant-related complications in children with Sillence type I, III and IV.

International orthopaedics
2024

Bleeding assessment in a large cohort of patients with Osteogenesis Imperfecta.

Orphanet journal of rare diseases
2024

Characteristics of femoral neck fractures in osteogenesis imperfecta: Series of four-teen consecutive hips in twelve patients.

Injury
2024

Early insights into the role of Exoc6B associated with spondyloepimetaphyseal dysplasia with joint laxity type 3 in primary ciliogenesis and chondrogenic differentiation in vitro.

Molecular biology reports
2024

Effect of Roflumilast, a Selective PDE4 Inhibitor, on Bone Phenotypes in ADO2 Mice.

Calcified tissue international
2024

Review of published 467 achondroplasia patients: clinical and mutational spectrum.

Orphanet journal of rare diseases
2024

Genetic Analysis, Phenotypic Spectrum and Functional Study of Rare Osteogenesis Imperfecta Caused by CRTAP Variants.

The Journal of clinical endocrinology and metabolism
2023

The incidence and management of slipped capital femoral epiphysis: a population-based study.

Acta orthopaedica Belgica
2024

Efficacy and Safety of Denosumab vs Zoledronic Acid in OI Adults: A Prospective, Open-Label, Randomized Study.

The Journal of clinical endocrinology and metabolism
2023

[Features and results of surgical rehabilitation of hearing loss in osteogenesis imperfecta].

Vestnik otorinolaringologii
2023

Trends in Serum Cytokine Expression in Pediatric Skeletal Dysplasia.

JBMR plus
2023

[Analysis of diet structure of Kashin-beck disease area in Chamdo-Lhorong of Tibet in 2021].

Wei sheng yan jiu = Journal of hygiene research
2024

The Effects of Residual Femoral Deformity on Computed Contact Mechanics in Patients Treated With In Situ Fixation for Slipped Capital Femoral Epiphysis.

Journal of pediatric orthopedics
2024

Genetic basis of osteogenesis imperfecta from a single tertiary centre in South Africa.

European journal of human genetics : EJHG
2024

Vosoritide therapy in children with achondroplasia aged 3-59 months: a multinational, randomised, double-blind, placebo-controlled, phase 2 trial.

The Lancet. Child &amp; adolescent health
2023

Distinct ClC-6 and ClC-7 Cl- sensitivities provide insight into ClC-7's role in lysosomal Cl- homeostasis.

The Journal of physiology
2023

Expanding the genetic and clinical spectrum of osteogenesis imperfecta: identification of novel rare pathogenic variants in type I collagen-encoding genes.

Frontiers in endocrinology
2023

Genetic testing and diagnostic strategies of fetal skeletal dysplasia: a preliminary study in Wuhan, China.

Orphanet journal of rare diseases
2023

A case-control study of early-stage radiological markers of endothelial dysfunction and cardiovascular findings in patients with osteogenesis imperfecta: genotype-phenotype correlations.

Journal of pediatric endocrinology &amp; metabolism : JPEM
2023

Growth Arrest in Type IV Osteogenesis Imperfecta After Fassier-Duval Rod Insertion Treated by a Lengthening Magnetic Intramedullary Nail: A Case Report.

JBJS case connector
2024

Temporal trends in surgical implants for in situ fixation of stable slipped capital femoral epiphysis.

Journal of pediatric orthopedics. Part B
2023

Novel HSPG2 Gene Mutation Causing Schwartz-Jampel Syndrome in a Moroccan Family: A Literature Review.

Genes
2025

Embryonic cranial cartilage defects in the Fgfr3Y367C /+ mouse model of achondroplasia.

Anatomical record (Hoboken, N.J. : 2007)
2023

A new test method for biochemical analysis of plasmalogens in dried blood spots and erythrocytes from patients with peroxisomal disorders.

Journal of inherited metabolic disease
2023

Scoliosis in osteogenesis imperfecta: identifying the genetic and non-genetic factors affecting severity and progression from longitudinal data of 290 patients.

Orphanet journal of rare diseases
2023

LRP5 high bone mass (Worth-type autosomal dominant endosteal hyperostosis): case report and historical review of the literature.

Archives of osteoporosis
2024

Cranio-cervical abnormalities in moderate-to-severe osteogenesis imperfecta - Genotypic and phenotypic determinants.

Orthodontics &amp; craniofacial research
2023

Exploration of charge transfer analysis and photovoltaics properties of A-D-A type non-fullerene phenazine based molecules to enhance the organic solar cell properties.

Journal of molecular graphics &amp; modelling
2023

Adult Osteopetrosis Type 2.

The Journal of the Association of Physicians of India
2023

Osteogenesis imperfecta type VIII: highlighting the need for genetic testing.

BMJ case reports
2023

Modified ulnar lengthening for correction of the Masada type 2 forearm deformity in hereditary multiple exostosis.

Scientific reports
2023

Molecular Mechanisms of Craniofacial and Dental Abnormalities in Osteopetrosis.

International journal of molecular sciences
2023

[Clinical and molecular genetic analysis of a child with Schmid type metaphyseal chondrodysplasia].

Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics
2023

[Analysis of COL1A1 and COL1A2 gene variants in two fetuses with osteogenesis imperfecta].

Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics
2023

Trichorhinophalangeal syndrome type 1 (TRPS1) expression in male breast carcinoma.

Human pathology
2023

Unravelling the pathogenesis of foramen magnum stenosis in patients with severe achondroplasia: a CT-based comparison with age-matched controls and FGFR3 craniosynostosis syndromes.

Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery
2023

RNA Sequencing of Urine-Derived Cells for the Characterization and Diagnosis of Osteogenesis Imperfecta.

Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research
2023

TAPT1-at the crossroads of extracellular matrix and signaling in Osteogenesis imperfecta.

EMBO molecular medicine
2024

Genotype-phenotype relationship and comparison between eastern and western patients with osteogenesis imperfecta.

Journal of endocrinological investigation
2024

Unravelling the Relacatib activity against the CTSK proteins causing pycnodysostosis: a molecular docking and dynamics approach.

Journal of biomolecular structure &amp; dynamics
2023

Case Report: short stature, kidney anomalies, and cerebral aneurysms in a novel homozygous mutation in the PCNT gene associated with microcephalic osteodysplastic primordial dwarfism type II.

Frontiers in endocrinology
2023

Cyclic intravenous pamidronate for an infant with osteogenesis imperfecta type II.

BMJ case reports
2023

Analysis of N-glycosylation protein of Kashin-Beck disease chondrocytes derived from induced pluripotent stem cells based on label-free strategies with LC-MS/MS.

Molecular omics
2023

CHST3-related skeletal dysplasia in 14 patients: Identification of 8 novel variants and further expansion of the phenotypic spectrum.

American journal of medical genetics. Part A
2023

Bone allografting: an original method for biological osteosynthesis and bone reinforcement in children with osteogenesis imperfecta.

International orthopaedics
2023

Intracranial aneurysm as a possible complication of osteogenesis imperfecta: a case series and literature review.

Endocrine journal
2023

Keratoconus tomographic indices in osteogenesis imperfecta.

Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie
2023

Multiple epiphyseal dysplasia tip 5: Case report a rare skeletal dysplasıa presenting with repetitive joint pain in children.

International journal of surgery case reports
2023

Route of delivery does not impact postnatal surgical morbidity in pregnancies affected by fetal achondroplasia.

Genetics in medicine : official journal of the American College of Medical Genetics
2023

Case Report: A Novel Homozygous Variant of the SERPINF1 Gene in Rare Osteogenesis Imperfecta Type VI.

International journal of molecular sciences
2023

[Clinical and genetic characteristics of 9 rare cases with coexistence of dual genetic diagnoses].

Zhonghua er ke za zhi = Chinese journal of pediatrics
2024

Genetic disruption of Ano5 leads to impaired osteoclastogenesis for gnathodiaphyseal dysplasia.

Oral diseases
2023

Novel mutation in LRP5 gene cause rare osteosclerosis: cases studies and literature review.

Molecular genetics and genomics : MGG
2023

Clinical value of RANKL, OPG, IL-6 and sclerostin as biomarkers for fibrous dysplasia/McCune-Albright syndrome.

Bone
2023

Expanding the Phenotypic Spectrum of Kenny-Caffey Syndrome.

The Journal of clinical endocrinology and metabolism
2023

Mitigating the Denosumab-Induced Rebound Phenomenon with Alternating Short- and Long-Acting Anti-resorptive Therapy in a Young Boy with Severe OI Type VI.

Calcified tissue international
2023

Expanding the clinical and molecular features of trichorhino- phalangeal syndrome with a novel variant.

The Turkish journal of pediatrics
2024

Early Results of 3-Dimensional Planning and Customized Cutting Guides for the Treatment of Severe Madelung Deformity.

The Journal of hand surgery
2023

Zebrafish Tric-b is required for skeletal development and bone cells differentiation.

Frontiers in endocrinology
2023

Growth patterns and outcomes of growth hormone therapy in patients with acrodysostosis.

Journal of endocrinological investigation
2023

Assessment of body fat mass, anthropometric measurement and cardiometabolic risk in children and adolescents with achondroplasia and hypochondroplasia.

Endocrine journal
2023

Dental Implants in Patients with Osteogenesis Imperfecta - Clinical and Radiographic Outcome in Six Patients.

Oral health &amp; preventive dentistry
2023

Genetic analysis of osteogenesis imperfecta in a large Brazilian cohort.

Bone
2023

Approach to the Patient: Pharmacological Therapies for Fracture Risk Reduction in Adults With Osteogenesis Imperfecta.

The Journal of clinical endocrinology and metabolism
2023

Genotypic and Phenotypic Spectrum and Pathogenesis of WNT1 Variants in a Large Cohort of Patients With OI/Osteoporosis.

The Journal of clinical endocrinology and metabolism
2023

CLCN7, a gene shared by autosomal recessive and autosomal dominant osteopetrosis.

Bone
2022

Characterization of a novel deep-intronic variant in DYNC2H1 identified by whole-exome sequencing in a patient with a lethal form of a short-rib thoracic dysplasia type III.

Cold Spring Harbor molecular case studies
2023

Clinical Manifestations and Outcomes of 20 Korean Hypochondroplasia Patients with the FGFR3 N540K variant.

Experimental and clinical endocrinology &amp; diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association
2023

Surgical outcomes for spinal deformity in osteogenesis imperfecta.

Spine deformity
2022

Cardiovascular abnormalities and its correlation with genotypes of children with osteogenesis imperfecta.

Frontiers in endocrinology
2022

Pediatric Hip Disease Increases the Risk for Opioid Use in Adulthood: Long-term Burden of Pain and Depression.

Pain physician
2023

Two Year Randomized Prospective Comparison of Ahmed Valve Versus Baerveldt Implant in Vitrectomized Eyes.

Journal of glaucoma
2022

A Novel lncRNA Mediates the Delayed Tooth Eruption of Cleidocranial Dysplasia.

Cells
2023

Clinical and Radiographic Features of the Atlantoaxial Dislocation Associated With Kashin-Beck Disease.

World neurosurgery
2022

Bone marrow transplantation as a therapy for autosomal dominant osteopetrosis type 2 in mice.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology
2022

Comparing Clinical and Genetic Characteristics of De Novo and Inherited COL1A1/COL1A2 Variants in a Large Chinese Cohort of Osteogenesis Imperfecta.

Frontiers in endocrinology
2022

Anterior cruciate ligament rupture in a patient with Albers-Schonberg disease.

BMC musculoskeletal disorders
2022

Prevention of Blindness in Stickler Syndrome.

Genes
2022

Autosomal Recessive Stickler Syndrome.

Genes
2022

[Ultrasonographic manifestation and genetic analysis of a fetus with Stickler syndrome].

Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics
2022

Pediatric patient with a bilateral Salter-Harris II fracture and slipped capital femoral epiphysis secondary to autosomal recessive osteopetrosis.

Orthopadie (Heidelberg, Germany)
2022

Genetic testing in four Indian families with suspected Stickler syndrome.

Indian journal of ophthalmology
2022

Metformin alleviates osteoarthritis in mice by inhibiting chondrocyte ferroptosis and improving subchondral osteosclerosis and angiogenesis.

Journal of orthopaedic surgery and research
2022

The MAP3K7 gene: Further delineation of clinical characteristics and genotype/phenotype correlations.

Human mutation
2022

Comprehensive literature review on the prevalence of comorbid conditions in patients with achondroplasia.

Bone
2022

A registry of achondroplasia: a 6-year experience from the Czechia and Slovak Republic.

Orphanet journal of rare diseases
2022

Mutations in COL1A1 and COL27A1 Associated with a Pectus Excavatum Phenotype in 2 Siblings with Osteogenesis Imperfecta.

The American journal of case reports
2022

Diagnostic distribution and postnatal evaluation of prenatally detected short femur: A single center experience.

American journal of medical genetics. Part A
2022

[Clinical features and FGFR3 mutations of children with achondroplasia].

Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics
2022

Phase 1 safety, tolerability, pharmacokinetics and pharmacodynamics results of a long-acting C-type natriuretic peptide prodrug, TransCon CNP.

British journal of clinical pharmacology
2022

Severe foveal hypoplasia and macular degeneration in Stickler syndrome caused by missense mutation in COL2A1 gene.

Ophthalmic genetics
2022

Novel NPR2 Gene Mutations Affect Chondrocytes Function via ER Stress in Short Stature.

Cells
2022

Effects of zoledronic acid therapy in fibrous dysplasia of bone: a single-center experience.

Archives of endocrinology and metabolism
2022

Comprehensive risk assessments and anesthetic management for children with osteogenesis imperfecta: A retrospective review of 252 orthopedic procedures over 5 years.

Paediatric anaesthesia
2022

Dominant osteogenesis imperfecta with low bone turnover caused by a heterozygous SP7 variant.

Bone
2022

When Is an Isolated Olecranon Fracture Pathognomonic for Osteogenesis Imperfecta?

Journal of pediatric orthopedics
2022

[Clinicopathological analysis of 105 patients with fibrous dysplasia of cranio-maxillofacial region].

Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences
2022

Do Patient Demographics and Socioeconomic Status Influence Severity and Time to Diagnosis in Children With Stable Slipped Capital Femoral Epiphysis?

Journal of pediatric orthopedics
2023

Impact of Patient and Tumor Characteristics on Range of Motion and Recurrence Following Treatment of Enchondromas of the Hand.

The Journal of hand surgery
2022

Targeting TGF-β for treatment of osteogenesis imperfecta.

The Journal of clinical investigation
2022

Standardizing genetic and metabolic consults for non-accidental trauma at a large pediatric academic center.

Child abuse &amp; neglect
2022

4PBA reduces growth deficiency in osteogenesis imperfecta by enhancing transition of hypertrophic chondrocytes to osteoblasts.

JCI insight
2021

[Analysis of COL1A1 gene variation and clinical prevention and treatment in patients with Van der Hoeve syndrome].

Zhonghua er bi yan hou tou jing wai ke za zhi = Chinese journal of otorhinolaryngology head and neck surgery
2022

A single-centre study of genetic mutations, audiology, echocardiogram and pulmonary function in Saudi children with osteogenesis imperfecta.

Journal of pediatric endocrinology &amp; metabolism : JPEM
2022

Animal model detects early pathologic changes of Charcot neuropathic arthropathy.

Annals of diagnostic pathology
2021

Muscle-bone properties after prolonged voluntary wheel running in a mouse model of dominant severe osteogenesis imperfecta.

Journal of musculoskeletal &amp; neuronal interactions
2022

Tibial Sliding Elastic Nailing Technique in Moderate-to-Severe Osteogenesis Imperfecta: Long-term Outcomes.

Journal of pediatric orthopedics
2022

Clinical, Biochemical, Radiological, Genetic and Therapeutic Analysis of Patients with COMP Gene Variants.

Calcified tissue international
2021

Multiomics landscape of the autosomal dominant osteopetrosis type II disease-specific induced pluripotent stem cells.

Hereditas
2022

SLC4A2 Deficiency Causes a New Type of Osteopetrosis.

Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research
2022

Development of individuals with thanatophoric dysplasia surviving beyond infancy.

Pediatrics international : official journal of the Japan Pediatric Society
2022

Enhanced Extracellular Matrix Degradation in Growth Plate Contributes to Manganese Deficiency-Induced Tibial Dyschondroplasia in Broiler Chicks.

Biological trace element research
2021

Generation of a heterozygous COL2A1 (p.G1113C) hypochondrogenesis mutation iPSC line, MCRIi019-A-7, using CRISPR/Cas9 gene editing.

Stem cell research
2022

Osteogenesis Imperfecta: The Impact of Genotype and Clinical Phenotype on Adiposity and Resting Energy Expenditure.

The Journal of clinical endocrinology and metabolism
2021

Osteogenesis Imperfecta and hearing loss in the paediatric population.

International journal of pediatric otorhinolaryngology
2021

Chloroquine increases osteoclast activity in vitro but does not improve the osteopetrotic bone phenotype of ADO2 mice.

Bone
2022

Craniocervical abnormalities in osteogenesis imperfecta type V.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA
2021

A novel homozygous mutation of the PCNT gene in a Chinese patient with microcephalic osteodysplastic primordial dwarfism type II.

Molecular genetics &amp; genomic medicine
2021

Tricorhinophalangeal Syndrome type 1: a novel variant and Perthes-like hip changes as first manifestation.

Acta reumatologica portuguesa
2021

A Novel Intronic Splicing Mutation in the EXT2 Gene of a Chinese Family with Multiple Osteochondroma.

Genetic testing and molecular biomarkers
2021

Neonatal Schwartz-Jampel syndrome type II: a rare case of peripheral origin of neonatal hypertonia.

BMJ case reports
2021

Clinical relevance of targeted exome sequencing in patients with rare syndromic short stature.

Orphanet journal of rare diseases
2021

Long-Term Follow-Up Outcomes of 19 Patients with Osteogenesis Imperfecta Type XI and Bruck Syndrome Type I Caused by FKBP10 Variants.

Calcified tissue international
2021

Real-time ultrasound-guided epidural anesthesia for cesarean section in a parturient with achondroplasia.

The Journal of international medical research
2021

Diagnostic utility of next-generation sequence genetic panel testing in children presenting with a clinically significant fracture history.

Archives of osteoporosis
2022

Patterns of femoral neck fracture and its treatment methods in patients with osteogenesis imperfecta.

Journal of pediatric orthopedics. Part B
2021

A GDF5 frameshift mutation segregating with Grebe type chondrodysplasia and brachydactyly type C+ in a 6 generations family: Clinical report and mini review.

European journal of medical genetics
2021

Fibrous Dysplasia at Unusual Anatomic Sites: A Series of 86 Cases With Emphasis on Histologic Patterns.

International journal of surgical pathology
Ver todos os 250 no EuropePMC

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Displasia epifisária múltipla tipo 7.

É de uma associação que acompanha esta doença? Fale com a gente →

Comunidades

Grupos ativos de quem convive com esta doença aqui no Raras

Ainda não existe comunidade no Raras para Displasia epifisária múltipla tipo 7

Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.

Tire suas dúvidas

Perguntas, dicas e experiências compartilhadas aqui na página

Participe da discussão

Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.

Fazer login

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Referências e fontes

Bases de dados externas citadas neste artigo

Publicações científicas

Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.

  1. Once-Weekly Navepegritide in Children With Achondroplasia: The APPROACH Randomized Clinical Trial.
    JAMA pediatrics· 2026· PMID 41247754mais citado
  2. Genetic and Clinical Spectrum of Osteogenesis Imperfecta in an Egyptian Cohort With a High Rate of Lethal Phenotypes.
    Clinical genetics· 2026· PMID 41090974mais citado
  3. Genotype-phenotype correlations in PSACH/EDM1 patients with COMP gene variants: a comprehensive review of 830 cases.
    Frontiers in endocrinology· 2026· PMID 41798190mais citado
  4. In Individuals with Osteogenesis Imperfecta, Cephalometric Findings Suggest that Bisphosphonate Therapy May Improve Craniofacial Growth.
    Calcified tissue international· 2026· PMID 41618006mais citado
  5. The SAPHO syndrome in diffuse sclerosing osteomyelitis of the mandible: an oral and maxillofacial surgery perspective.
    Oral surgery, oral medicine, oral pathology and oral radiology· 2026· PMID 41109770mais citado
  6. X-Linked Spondyloepiphyseal Dysplasia Tarda.
    · 1993· PMID 20301324recente
  7. Human pluripotent stem cell model of multiple epiphyseal dysplasia with MATN3 mutation identifies altered matrix organisation and upregulation of the cholesterol biosynthesis pathway.
    Osteoarthritis Cartilage· 2026· PMID 41651153recente
  8. Elevated MMP9 Expression-A Potential In Vitro Biomarker for COMPopathies.
    Int J Mol Sci· 2025· PMID 41465495recente
  9. Exome Sequencing Identifies a Novel Splicing Variant in COL9A3 Resulting in Multiple Epiphyseal Dysplasia: A Case Report.
    Mol Genet Genomic Med· 2025· PMID 41194747recente

Bases de dados e fontes oficiais

Identificadores e referências canônicas usadas para montar este verbete.

  1. ORPHA:647676(Orphanet)
  2. OMIM OMIM:617719(OMIM)
  3. MONDO:0054680(MONDO)
  4. Variantes catalogadas(ClinVar)
  5. Busca completa no PubMed(PubMed)
  6. Q60195172(Wikidata)

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Displasia epifisária múltipla tipo 7
Compêndio · Raras BR

Displasia epifisária múltipla tipo 7

ORPHA:647676 · MONDO:0054680
Prevalência
<1 / 1 000 000
Casos
2 casos conhecidos
CID-10
Q77.3 · Condrodisplasia puntacta
Início
Childhood
Prevalência
0.0 (Worldwide)
MedGen
UMLS
C4540251
EuropePMC
Wikidata
Papers 10a
DiscussaoAtiva

Nenhuma novidade ainda. O agente esta monitorando.

0membros
0novidades